In human patients with symptomatic epilepsies, the regulation of the GluN2B subunit of the NMDAR complex via NRG1-ErbB4-Src signaling pathways was identified as a potential modulating target through the use of the immunoblotting technique [69]. This evidence concerns the gene GRIN2B and epilepsy.